Shanghai, China

Xiaoyan Su

This inventor holds 3 USPTO granted patents. Top assignee: Viva Biotech (Shanghai) Ltd.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoyan Su. Retrieved from https://idiyas.com/inventor/xiaoyan-su-a7rxuha9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaoyan Su in G-Protein Coupled Receptor Research

Introduction

Xiaoyan Su is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biochemistry, particularly in the study of G-protein coupled receptors (GPCRs). With a total of 3 patents, her work focuses on improving the expression and stability of these important proteins.

Latest Patents

Xiaoyan Su's latest patents include innovative methods for expressing GPCR proteins. One of her notable inventions is a method that utilizes fusion proteins to enhance the yield and stability of GPCRs when purified from mammalian cells. This method involves using fragments from APJ protein, RGS16 protein, or DNJ protein, which have over 90% homology to the respective protein fragments. These advancements can significantly aid in the study and application of GPCR proteins in various research settings.

Career Highlights

Xiaoyan Su is currently employed at Viva Biotech (Shanghai) Ltd., where she continues to push the boundaries of biotechnological research. Her work has garnered attention for its potential applications in drug discovery and therapeutic development.

Collaborations

Some of her notable coworkers include Jianhua Cai and Jian Shen, who contribute to her research endeavors and collaborative projects.

Conclusion

Xiaoyan Su's innovative approaches to GPCR research exemplify the importance of advancements in biochemistry. Her patents not only enhance our understanding of these proteins but also pave the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…